Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Sales | 910,373 | 938,509 | 891,990 | 727,844 | 676,694 |
| Cost of Goods | 475,955 | 470,144 | 463,859 | 358,604 | 321,485 |
| Gross Profit | 434,418 | 468,365 | 428,131 | 369,240 | 355,209 |
| Operating Expenses | 394,833 | 422,077 | 372,553 | 281,086 | 245,146 |
| Operating Income | 40,540 | 46,432 | 56,437 | 88,758 | 110,548 |
| Other Income | -9,375 | -10,031 | -6,540 | 740 | -467 |
| Pre-tax Income | 31,165 | 36,401 | 49,897 | 89,498 | 110,081 |
| Income Tax | 14,268 | 1,253 | 11,097 | 22,612 | 30,101 |
| Net Income Continuous | 16,897 | 35,148 | 38,800 | 66,886 | 79,980 |
| Net Income | $16,897 | $35,148 | $38,800 | $66,886 | $79,980 |
| EPS Basic Total Ops | 0.33 | 0.68 | 0.76 | 1.32 | 1.59 |
| EPS Basic Continuous Ops | 0.33 | 0.68 | 0.76 | 1.32 | 1.59 |
| EPS Diluted Total Ops | 0.32 | 0.67 | 0.74 | 1.30 | 1.56 |
| EPS Diluted Continuous Ops | 0.32 | 0.67 | 0.74 | 1.30 | 1.56 |
| EBITDA(a) | $126,593 | $128,172 | $123,057 | $138,724 | $158,693 |